202 related articles for article (PubMed ID: 3279137)
1. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
[TBL] [Abstract][Full Text] [Related]
2. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
Cunnion KM; Hair PS; Buescher ES
Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
[TBL] [Abstract][Full Text] [Related]
4. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
[TBL] [Abstract][Full Text] [Related]
5. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
Kozel TR; Pfrommer GS
Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
[TBL] [Abstract][Full Text] [Related]
6. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
7. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
9. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
Olesen EH; Johnson AA; Damgaard G; Leslie RG
Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
[TBL] [Abstract][Full Text] [Related]
10. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
11. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
12. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
Cunnion KM; Buescher ES; Hair PS
J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
[TBL] [Abstract][Full Text] [Related]
14. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
15. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
Hostetter MK
J Infect Dis; 1986 Apr; 153(4):682-93. PubMed ID: 3950449
[TBL] [Abstract][Full Text] [Related]
16. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
17. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.
Cunnion KM; Zhang HM; Frank MM
Infect Immun; 2003 Feb; 71(2):656-62. PubMed ID: 12540542
[TBL] [Abstract][Full Text] [Related]
18. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
19. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.
Kozel TR; Wilson MA; Farrell TP; Levitz SM
Infect Immun; 1989 Nov; 57(11):3412-7. PubMed ID: 2680973
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.
Koch TK; Reuter M; Barthel D; Böhm S; van den Elsen J; Kraiczy P; Zipfel PF; Skerka C
PLoS One; 2012; 7(10):e47638. PubMed ID: 23071827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]